Purpose of the Test
- Identify genetic mutations causing atypical malignancies.
- Provide genomic data to personalize chemotherapy or immunotherapy.
- Detect hereditary syndromes associated with rare tumor presentations.
An advanced genomic analysis covering protein-coding regions to identify rare mutations in atypical cancer presentations, providing crucial insights for precise diagnostic accuracy and personalized treatment strategies.
Scientific name: Whole Exome Sequencing (WES) for Rare Malignancies
A sophisticated laboratory test analyzing the entire exome sequence to detect rare genetic mutations linked to malignancies. It aids clinicians in identifying precise therapeutic targets for atypical cancers.